Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Initiation of phase IIa study evaluating BGE-117 in elderly with unexplained anemia

Feb. 26, 2021

Enrollment completed in phase II study of SSS-06 long-acting erythropoietin-stimulating protein

Feb. 25, 2021

New phase I study evaluates AbFero's SP-420 to treat transfusional iron overload

Feb. 24, 2021

New coagulation factor XIa inhibitors identified at Medshine Discovery

Feb. 17, 2021

bluebird bio temporary suspends studies of LentiGlobin gene therapy for SCD

Feb. 17, 2021

New phase I/II trial investigates JSP-191 in sickle cell disease

Feb. 12, 2021

Enrollment ongoing in phase III study of LNP-023 in adults with PNH with residual anemia

Feb. 11, 2021

KalVista releases phase II data on KVD-900 as oral on-demand treatment for HAE

Feb. 9, 2021

Phase I/II results for TAK-754 gene therapy in severe hemophilia A

Feb. 8, 2021

Updated patient eligibility and first-in-human data for BAY-2599023

Feb. 8, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....